PharmaBoardroom

Top 10 Chinese Pharma Companies 2020

The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken from Fortune magazine's 2020 list of the 500 biggest companies in…

Ichnos CEO on Glenmark Legacy, Biotech Transformation &…

After an illustrious career in oncology R&D, contributing greatly to the development of cutting-edge cancer therapies at Novartis and Gilead,…

Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for…

The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical company successfully listed on…

Swiss Pharma: Staying the Course

This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive up-to-date country report on the Swiss…

Brian O’Callaghan – CEO, ObsEva

Biotech veteran Brian O’Callaghan introduces ObsEva – a Swiss-based firm focused on women’s health –, his motivations to join the company –…

Latvia: Striving to Catch Up to its Neighbours on Innovation…

Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals Manufacturers of Latvia (SIFFA), outlines the…

Bertrand Ducrey – CEO, Debiopharm

In a wide-ranging interview CEO Bertrand Ducrey introduces Debiopharm’s unique business focus on drug improvement, drug delivery, and drug…

Europe: EMA Medicine Approvals 2020

The full list of medicines recommended for approval by the European Medicines Agency (EMA) in 2020 divided by therapeutic area and with drugs that…

Canada: Federal Consultations on a National Strategy for Rare…

Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health Canada's consultation with Canadians on…

Accelerated Regulatory Assessment of Innovative Medicines in…

Writing in the March edition of DIA’s Global Forum magazine, EMD Serono's Ana Padua outlines the findings of a recent study into accelerated…

Nicolas Fischer – CEO, Light Chain Bioscience

Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and development of bispecific antibodies using…

Alessandro Riva – CEO, Ichnos Sciences

Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in oncology R&D at Novartis and…

Tagged with OP